Company Monitoring Page for Novo-Nordisk

latest headlines for company on cafepharma

Novo Nordisk resumes shipments of Wegovy 1.7 mg dose in US
Reuters
Mon, 01/15/24 - 09:36 am
Tags:
Novo Nordisk, Wegovy
Roche is ‘on par’ with Novo, Lilly in GLP-1 race after $2.7B Carmot deal
Medical Devices and Diagnostics Industry
Fri, 01/12/24 - 11:33 am
Tags:
Roche, Carmot, GLP-1 agonist. obesity, Novo Nordisk, Eli Lilly
FDA says no evidence yet linking weight loss drugs to suicidal thoughts
Reuters
Thu, 01/11/24 - 11:35 am
Tags:
Novo Nordisk, Eli Lilly, weight loss, GLP-1 agonist, FDA
JPM24: ‘Diabesity’ duopoly between Novo, Lilly takes center stage
Medical Marketing and Media
Thu, 01/11/24 - 11:18 am
Tags:
JPMHC 2024, obesity, diabetes, diabesity, Novo Nordisk, Eli Lilly
JPM24: In booming obesity field, Novo Nordisk is 'just getting going,' CEO says
Fierce Pharma
Wed, 01/10/24 - 06:27 pm
Tags:
Novo Nordisk, obesity, Wegovy, Lars Fruergaard Jorgensen, JPMHC 2024
Ozempic not tied to pancreatic cancer risk, study suggests
Beckers Hospital Review
Tue, 01/9/24 - 10:04 pm
Tags:
Ozempic, Trulicity, type 2 diabetes, Novo Nordisk, GLP-1 agonist, pancreatic cancer
Novo CEO expects patients to stay on Wegovy longer than older weight loss drugs
Reuters
Tue, 01/9/24 - 09:59 pm
Tags:
Novo Nordisk, Pharma CEOs, Wegovy, patients, Lars Fruergaard Jorgensen, JPMHC 2024
Wegovy, Ozempic not linked to increase in suicidal thoughts, US study finds
Reuters
Fri, 01/5/24 - 09:55 am
Tags:
Novo Nordisk, Wegovy, Ozempic, side effects
Novo Nordisk, Eli Lilly's weight-loss drugs under FDA scrutiny for suicidal thoughts, hair loss
Fierce Pharma
Thu, 01/4/24 - 11:53 am
Tags:
Novo Nordisk, Eli Lilly, weightloss, side effects, Ozempic, Wegovy, Zepbound
Novo Nordisk offers 2 Flagship biotechs up to $1B total for obesity, MASH deals
Fierce Biotech
Thu, 01/4/24 - 10:06 am
Tags:
Novo Nordisk, Omega Therapeutics, Cellarity, Flagship Pioneering, funding, obesity, NASH, MASH
Novo Nordisk to open new AI research hub in London
Biopharma Reporter
Tue, 01/2/24 - 09:47 am
Tags:
Novo Nordisk, artificial intelligence, London, UK, R&D
Novo Nordisk submits application for massive manufacturing campus near Dublin
Fierce Pharma
Sun, 12/31/23 - 11:57 am
Tags:
Novo Nordisk, Ireland, drug manufacturing, Ozempic, Wegovy
FDA warns about counterfeit versions of Novo's diabetes drug Ozempic
Reuters
Fri, 12/22/23 - 09:40 am
Tags:
Novo Nordisk, FDA, Ozempic, diabetes, drug counterfeiting
Obesity drugs’ next tests, and rising threats: 3 chronic disease stories to watch
Stat
Thu, 12/21/23 - 09:52 am
Tags:
obesity, climate change, Wegovy, Zepbound, Novo Nordisk, Eli Lilly, liver disease
Obesity drug Mounjaro to surpass Ozempic with $27 billion sales in 2029
Biopharma Reporter
Mon, 12/18/23 - 11:37 am
Tags:
Eli Lilly, Novo Nordisk, obesity, weight loss, Ozempic, Mounjaro
Novo owner commits $265 mln of Wegovy windfall to respiratory diseases
Reuters
Mon, 12/18/23 - 10:22 am
Tags:
Novo Nordisk, Wegovy, vaccines, respiratory disease
IndiaMART is working with Novo Nordisk to halt illegal Wegovy sales -source
Reuters
Sun, 12/17/23 - 09:57 pm
Tags:
India, Novo Nordisk, Wegovy, weight loss
Fractyl, hoping its GLP-1 gene therapy can take on Wegovy, plans IPO
Fierce Biotech
Fri, 12/15/23 - 09:41 am
Tags:
Fractyl Health, IPOs, Novo Nordisk, Wegovy, GLP-1 agonist
US employers hire virtual providers as weight-loss drug gatekeepers
Reuters
Wed, 12/13/23 - 09:38 am
Tags:
Novo Nordisk, Wegovy, weight loss, Teladoc
US diabetes patients face delays as insurers tighten Ozempic coverage
Reuters
Tue, 12/12/23 - 10:03 am
Tags:
Novo Nordisk, type 2 diabetes, Ozempic, insurers

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.